| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner
30 companies
Sandell Scott D is a 10% Owner at SVRA with holdings across 30 companies. Recent SEC Form 4 filings include 3 buys and 14 sells.
Estimated insider holdings value: $1827.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2020 | Director, 10% Owner | Sell | 92,163 | $37.38 | $3,445,508.31 | -3.4% | ||
| Jul 14, 2020 | NKTX Nkarta, Inc. | 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +29.8% | |
| Jun 15, 2020 | ARDX Ardelyx, Inc. | 10% Owner | Sell | 43 | $6.37 | $273.91 | -100% | |
| Jun 12, 2020 | ARDX Ardelyx, Inc. | 10% Owner | Sell | 89,983 | $6.37 | $573,146.77 | -66.6% | |
| May 21, 2020 | Director, 10% Owner | Sell | 349,554 | $27.57 | $9,636,731.83 | -49.7% | ||
| Apr 14, 2020 | 10% Owner | Sell | 2,198 | $9.04 | $19,864.61 | -100% | ||
| Apr 13, 2020 | 10% Owner | Sell | 20,914 | $8.50 | $177,775.27 | -100% | ||
| Apr 3, 2020 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Sell | 564 | $2.66 | $1,500.24 | - | |
| Jan 24, 2020 | 10% Owner | Buy | 7,500,000 | $0.67 | $5,000,250.00 | +62.5% | ||
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +12.0% |